- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| Mo | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 13.11. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | 1 | ASX | ||
| 12.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 11.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 10.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 10.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 06.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 05.11. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | 1 | ASX | ||
| 03.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 03.11. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 30.10. | VITA LIFE SCIENCES LIMITED: Daily share buy-back notice - Appendix 3E | - | ASX | ||
| 30.09. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 27.09. | VITA LIFE SCIENCES LIMITED: Notification regarding unquoted securities - VLS | - | ASX | ||
| 26.08. | VITA LIFE SCIENCES LIMITED: Dividend/Distribution - VLS | - | ASX | ||
| 26.08. | VITA LIFE SCIENCES LIMITED: Half Year Presentation | - | ASX | ||
| 26.08. | VITA LIFE SCIENCES LIMITED: Half Year Accounts | - | ASX | ||
| 13.06. | VITA LIFE SCIENCES LIMITED: Guidance | - | ASX | ||
| 07.06. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 07.06. | VITA LIFE SCIENCES LIMITED: Cleansing Statement | - | ASX |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GREEN THUMB INDUSTRIES | 9,000 | -1,32 % | Grünes Gold!: Gesundheit so wichtig wie nie! Medizinische Revolution durch diese Aktie! | ||
| INDIVA | 0,016 | -100,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 233,60 | -1,06 % | Alnylam Presents New Phase 1 Results For Next-Gen RNAi Therapy Nucresiran In ATTR Amyloidosis | WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) has shared new findings from its Phase 1 study of nucresiran (previously known as ALN-TTRsc04), a next-generation RNAi therapy being... ► Artikel lesen | |
| CASSAVA SCIENCES | 25,470 | +2,99 % | Cassava Sciences, Inc.: Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer | ||
| NEKTAR THERAPEUTICS | 0,933 | -2,25 % | Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence | - NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions -
SAN FRANCISCO, Nov. 18,... ► Artikel lesen | |
| ADASTRA | 0,457 | +0,44 % | Adastra Holdings Ltd.: Adastra Holdings Announces Sale of Perceive MD | Langley, British Columbia--(Newsfile Corp. - November 6, 2024) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 15,300 | -0,94 % | Acadia Pharmaceuticals Inc - On Nov 18, Co Involuntarily Terminates COO Brendan Teehan | ||
| SELLAS LIFE SCIENCES | 1,240 | +5,80 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update | - Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 - - Data from the Phase 2a Trial of SLS009 in Relapsed/Refractory... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 20,090 | +0,10 % | Vorstandsvorsitzender von Catalyst Pharmaceuticals verkauft Aktien im Wert von 3,1 Millionen US-Dollar | ||
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule enterss contract manufacturing deal | ||
| NUMINUS WELLNESS | 0,015 | -44,03 % | Numinus Applies for Management Cease Trade Order | ||
| OPUS GENETICS | 0,949 | +2,48 % | Foundation Fighting Blindness: The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics | The resulting company will operate under the name Opus Genetics and the Nasdaq ticker symbol (IRD)
RALEIGH, N.C., Oct. 25, 2024 /PRNewswire/ -- The RD Fund (Retinal... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,400 | -0,50 % | ZELIRA THERAPEUTICS LIMITED: Zelira to present at Automic Invest 2024 conference | ||
| SOLIGENIX | 3,510 | 0,00 % | Soligenix, Inc.: Soligenix to Present at November 21st Virtual Investor Summit Microcap Event | PRINCETON, NJ / ACCESSWIRE / November 15, 2024 / Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 51,00 | -1,92 % | ANI PHARMACEUTICALS INC - 8-K, Current Report |
Das Unternehmen VITA LIFE SCIENCES LIMITED kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.
